William H. Milliken is a director in Sterne Kessler’s Trial & Appellate and Electronic Practice Groups. Will is co-chair of the firm’s appellate practice and focuses on patent litigation in the United States Court of Appeals for the Federal Circuit, federal district courts, the International Trade Commission, and the Patent Trial and Appeal Board. He has extensive experience trying patent infringement cases in district court and briefing and arguing Federal Circuit appeals and complex motions. His clients include leading companies in the hi-tech, consumer products, pharmaceutical, and manufacturing industries.

Will is particularly well-known for his work in the U.S. Court of Appeals for the Federal Circuit, where he leverages his deep knowledge of procedural and substantive appellate law to achieve successful outcomes for his clients.

Will also has an extensive pro bono practice focusing on veterans’ appeals and Eighth Amendment issues. He has litigated in the U.S. Supreme Court, the U.S. Court of Appeals for the Federal Circuit, and the federal district courts on behalf of veterans seeking disability benefits and incarcerated individuals seeking habeas corpus.

Will is an Adjunct Professor of Law at the Antonin Scalia Law School of George Mason University, where he teaches an upper-level seminar on Patent Office litigation.

Will graduated first in his class at Vanderbilt University with a B.A. in mathematics and received his J.D., magna cum laude, from Harvard Law School. While at Harvard, Will was a winner of the Ames Moot Court Competition and served as executive editor of the Harvard Law & Policy Review. After law school, he clerked on the United States District Court for the Eastern District of Louisiana and the United States Court of Appeals for the First Circuit. He has authored two law review articles on constitutional criminal procedure and has written several problems for Harvard Law School’s moot court competition.

In addition to patent litigation, Will enjoys skiing, running, playing guitar, and spending time with his wife and his dogs Lulu and Rocco.

Technical Publications

  • Retroactivity, the Due Process Clause, and the Federal Question in Montgomery v. Louisiana, 68 Stan. L. Rev. Online 42 (with Jason Zarrow) (2015)
  • The Retroactivity of Substantive Rules to Cases on Collateral Review and the AEDPA, With A Special Focus on Miller v. Alabama, 48 Ind. L. Rev. 931 (with Jason Zarrow) (2015)

  • MiiCs & Partners America, Inc v. Funai Electric Co., Ltd., C.A. No. 14-804-RGA (D. Del.)
  • Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc., C.A. No. 2:15-cv-1471-JRG-RSP (E.D. Tex.)
  • Allergan, Inc. v. Teva Pharmaceuticals USA, C.A. No. 2:15-cv-1455-WCB (E.D. Tex.)

  • Patexia, “100 Most Active CAFC Attorneys Representing Patent Appellants (Top 10)” (2022)
  • Patexia, “100 Most Active CAFC Attorneys Overall (Representing Appellants and Appellees) (Top 50)” (2022)
  • Patexia, “100 Best Performing CAFC Attorneys Representing Appellees (Top 50)” (2022)
  • Patexia, “100 Best Performing CAFC Attorneys Representing Appellants (Top 50)” (2022)
  • Patexia, “100 Best Performing CAFC Attorneys Overall (Representing Appellants or Appellees) (Top 50)” (2022)

  • J.D., Harvard Law School, magna cum laude
  • B.A., Mathematics, Vanderbilt University, summa cum laude

  • District of Columbia
  • District of Columbia Court of Appeals
  • Supreme Court of the United States
  • Tennessee
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the First Circuit
  • U.S. Court of Appeals for the Ninth Circuit

  • U.S. Court of Appeals for the First Circuit
  • U.S. District Court for the Eastern District of Louisiana

Webinar

Federal Circuit IP Appeals: Summaries of Key 2023 Decisions

Virtual, January 23, 2024 1:00 PM - 2:00 PM PST

Speaking Engagement

2023 Focus on Pharma

Washington, DC, April 14, 2023 8:30 AM - 6:00 PM PST

Webinar

ENCORE: Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

Virtual, February 16, 2023 1:00 PM - 2:00 PM PST

Webinar

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

Virtual, February 2, 2023 1:00 PM - 2:00 PM PST

Speaking Engagement

Pro Bono “Now and Zen”: Views from the Bench & Bar

Sea Island, GA, Sea Island Resort, June 17, 2022 12:00 PM - 1:00 PM PST

Webinar

An Expert Guide to Appeals: U.S. Court of Appeals for the Federal Circuit [Boardroom]

Virtual, April 28, 2022 9:00 AM - 10:00 AM PST

Webinar

Preparing for PTAB and US ITC Appeals and Potential Litigation Processes

Virtual, April 14, 2022 11:00 AM - 12:00 PM PST

Webinar

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Virtual, February 17, 2022 1:00 PM - 2:00 PM PST

Speaking Engagement

Appeals from the PTAB

Washington, DC, The Ritz-Carlton, Washington, DC, September 23, 2021 2:10 PM - 2:55 PM PST

Related Resources

From William H. Milliken

In the News

February 28, 2024

Jury Awards Wirtgen $12.9M Against Caterpillar in Milling Machine Lawsuit

Equipment World

Firm Announcements

February 27, 2024

Sterne Kessler and Patterson IP Law Team Up to Secure $12.9M Wirtgen Win Over Caterpillar

Sterne, Kessler, Goldstein & Fox

In the News

February 27, 2024

Caterpillar Owes Deere $13 Million in Road-Milling Patent Trial

Bloomberg Law

In the News

February 26, 2024

Caterpillar to Pay Wirtgen $12.9M in Damages After Patent Battle

Construction Briefing

In the News

January 26, 2024

Trials After PTAB Invalidity Rulings Present Tricky Issues

Law360

In the News

January 25, 2024

Petition Watch: Patent Obviousness, ADA Trials, Spoofing

Law360

Bylined Articles

January 24, 2024

Introduction (Federal Circuit IP Appeals: Summaries of Key 2023 Decisions)

Sterne, Kessler, Goldstein & Fox William H. Milliken, Michael Joffre, Ph.D.

Webinar Recordings & Materials

January 23, 2024

Federal Circuit IP Appeals: Summaries of Key 2023 Decisions

William H. Milliken, Michael Joffre, Ph.D.

Client Alert

January 21, 2024

IP Hot Topic: Sterne Kessler has Published Federal Circuit IP Appeals: Summaries of Key 2023 Decisions Report

William H. Milliken, Michael Joffre, Ph.D.

In the News

January 9, 2024

Teva Pharmaceuticals Successfully Defends Against Allegations of Patent Infringement

Parsippany Focus William H. Milliken, Michael Joffre, Ph.D.

Bylined Articles

January 8, 2024

Hyatt v Vidal: the penultimate chapter in patent law’s longest saga?

Managing IP Multiple Authors

In the News

January 3, 2024

Teva Defeats Infringement Claims on Endocrine Drug

New Jersey Law Journal Multiple Authors

Firm Announcements

January 3, 2024

Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

December 18, 2023

VW To Settle Part Of Cellular Tech Patent Fight With Neo

Law360 Multiple Authors

Bylined Articles

December 7, 2023

Analyzing the ITC's impending import ban on Apple watches

Reuters Multiple Authors

In the News

November 16, 2023

Delaware Jury: Guardant Willfully Infringed Patents With DNA Sequencing Kits

Mealey's Litigation Report: Intellectual Property, pub. 41094 William H. Milliken

In the News

November 15, 2023

Seattle Startup Wins $83M In IP Spat With Silicon Valley Rival

Law360 William H. Milliken

In the News

November 15, 2023

Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says

Reuters William H. Milliken

Firm Announcements

November 15, 2023

Sterne Kessler Scores $83.4M Federal Jury Verdict for TwinStrand Biosciences, Inc.

Sterne, Kessler, Goldstein & Fox William H. Milliken

Firm Announcements

November 15, 2023

Sterne Kessler Scores $83.4M Federal Jury Verdict for TwinStrand Biosciences, Inc.

Sterne, Kessler, Goldstein & Fox William H. Milliken

Firm Announcements

August 30, 2023

Federal Circuit Affirms York County Prison District Court Win Finding Smart Communications’ Mail Processing Patent Ineligible for Patenting

Sterne, Kessler, Goldstein & Fox William H. Milliken

Bylined Articles

August 25, 2023

From Warhol to War on HAL: Copyright Infringement and Fair Use as Applied to Artificial Intelligence After the Supreme Court’s Warhol Decision

The Journal of Robotics, Artificial Intelligence & Law Multiple Authors

In the News

August 9, 2023

Don’t Be a ‘Guinea Pig’ After Medtronic Fed Circuit Case: Counsel

Managing IP Multiple Authors

Bylined Articles

July 31, 2023

Is Federal Circuit on the Verge of Upending Harmonious Co-Existence Between Design Patents and Utility Patents?

Thomson Reuters Westlaw Today Multiple Authors

In the News

July 7, 2023

Why PTAB Attys Should Watch the High Court's SEC Fight

Law360 Multiple Authors

Bylined Articles

June 13, 2023

The Supreme Court Takes Enablement Law Back to Basics

The Patent Lawyer William H. Milliken

MarkIt to Market®

May 31, 2023

MarkIt to Market® - May 2023

Multiple Authors

Bylined Articles

May 26, 2023

Why the Amgen Case Might Be About More Than Enablement

Thomson Reuters Westlaw Today William H. Milliken

In the News

May 22, 2023

Reactions to Amgen: Hard Work Ahead for Biotech Innovators and Attorneys Trying to Enable Genus Claims

IPWatchdog William H. Milliken, Michael Joffre, Ph.D.

In the News

May 19, 2023

Sanofi Can Thank Thomas Edison And Samuel Morse For IP Win

The National Law Journal William H. Milliken, Michael Joffre, Ph.D.

In the News

May 19, 2023

In Amgen-Sanofi Decision, High Court Sticks to Patent Law Script

Bloomberg Law William H. Milliken, Michael Joffre, Ph.D.

Client Alert

May 19, 2023

US Supreme Court Refocuses the Test for Transformative Use

Ivy Clarice Estoesta, William H. Milliken

Client Alert

May 18, 2023

Supreme Court Affirms Federal Circuit’s Decision in Amgen v. Sanofi

William H. Milliken, Michael Joffre, Ph.D.

In the News

May 15, 2023

What's Next For Patent Eligibility After Latest Denials?

Law360 William H. Milliken, Michael Joffre, Ph.D.

In the News

May 10, 2023

Sterne Kessler Team Scores Federal Circuit Win for Teva in Sleep Disorder Drug Litigation

Law360 William H. Milliken, Michael Joffre, Ph.D.

In the News

May 10, 2023

Sterne Kessler Represents Teva in Sleep Disorder Drug Win at Federal Circuit

Bloomberg Law William H. Milliken, Michael Joffre, Ph.D.

Bylined Articles

May 4, 2023

Preserving Issues for Appeal: How a Prison Litigation Case May Affect Patent Law

Thomson Reuters Westlaw Today Multiple Authors

In the News

April 14, 2023

DNA Collection Program Run by Orange County DA Can Face Challenge

Daily Journal Multiple Authors

In the News

April 14, 2023

Calif. Court OKs Challenge to 'Spit and Acquit' DNA Collection

Law360 Multiple Authors

Firm Announcements

April 13, 2023

Sterne Kessler Helps Score Pro Bono Win in Case Challenging Constitutionality of Orange County “Spit and Acquit” DNA Collection Program

Sterne, Kessler, Goldstein & Fox Multiple Authors

Client Alert

April 3, 2023

IP Hot Topic: 4 Potential Paths for High Court in Amgen Patent Case

William H. Milliken

Bylined Articles

March 31, 2023

4 Potential Paths for High Court in Amgen Patent Case

Law360 William H. Milliken

In the News

March 29, 2023

Counsel Predict Sanofi Victory in SCOTUS Enablement Case

Managing IP William H. Milliken

In the News

March 28, 2023

Supreme Court Brief: Fact-Dependent IP Hearing | ADA ‘Tester’ Case

Supreme Court Brief William H. Milliken

In the News

March 28, 2023

Practitioners Mostly Agree Amgen Won’t Be a Sea Change, But Some Predict Grim Consequences

IPWatchdog William H. Milliken

Client Alert

March 21, 2023

Sterne Kessler To Live Tweet SCOTUS Oral Arguments in Amgen Inc. v. Sanofi

William H. Milliken

In the News

March 15, 2023

Shibuya Sheds $38 Million Patent Loss With Noninfringement Order

Bloomberg Law William H. Milliken

In the News

March 14, 2023

Fed. Circ. Unsure Vanda's Sleep Med Hetlioz Is Patentable

Law360 William H. Milliken

In the News

March 14, 2023

In Win for Client Shibuya, Judge Overturns Steuben Foods' $38M Patent Trial Win

Law360 William H. Milliken

Webinar Recordings & Materials

February 16, 2023

ENCORE: Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

William H. Milliken

Bylined Articles

February 15, 2023

Bad Spaniel's: Barking the Line Between Permitted Parody and Trademark Infringement

Westlaw Today Multiple Authors

Press Release

February 7, 2023

Sterne Kessler Publishes Report Examining Key 2022 Federal Circuit Rulings on PTAB and ITC Appeals

Sterne, Kessler, Goldstein & Fox Multiple Authors

Reports

February 6, 2023

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

February 6, 2023

Introduction – Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

Sterne, Kessler, Goldstein & Fox Michael Joffre, Ph.D.

Bylined Articles

February 6, 2023

Nippon Shinyaku Co. v. Sarepta Therapeutics, Inc., 25 F.4th 998 (Fed. Cir. 2022) (Newman, Lourie, Stoll)

Sterne, Kessler, Goldstein & Fox William H. Milliken

Bylined Articles

February 6, 2023

Arthrex, Inc. v. Smith & Nephew, Inc., 35 F.4th 1328 (Fed. Cir. 2022) (Moore, Reyna, Chen)

Sterne, Kessler, Goldstein & Fox William H. Milliken

Webinar Recordings & Materials

February 2, 2023

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions

William H. Milliken

Firm Announcements

January 25, 2023

Sterne Kessler Scores Another District Court Patent Win for Client Block Inc.

Sterne, Kessler, Goldstein & Fox William H. Milliken

In the News

January 25, 2023

Tidal Escapes Patent Suit Over Music Playlist Tech

Law360 William H. Milliken

In the News

January 3, 2023

Fed. Circ. Won't Bar Generic Sleep Meds Amid Vanda Appeal

Law360 William H. Milliken

In the News

January 2, 2023

Patent Cases To Watch in 2023

Law360 William H. Milliken

In the News

December 13, 2022

Teva, Apotex Win Ax of Patents in Sleep Drug Suit

Law360 William H. Milliken

In the News

December 1, 2022

Patexia Insight 161: Top CAFC Law Firms of 2022

Patexia William H. Milliken

Bylined Articles

November 30, 2022

Supreme Court Poised To Alter Patentability of Pharmaceutical, Life-Science Innovations

Westlaw Today Multiple Authors

In the News

November 22, 2022

Fed. Circ. Rejects Mandamus Bids To End Ex Parte Reexams

Law360 Multiple Authors

Press Release

November 21, 2022

Sterne Kessler and Its Attorneys Ranked Highly for Appellate Practice in Patexia’s 2022 CAFC Intelligence Report

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

November 3, 2022

Ruling May Spur New Patent Venue Rows Over Remote Work

Law360 Multiple Authors

MarkIt to Market®

October 28, 2022

MarkIt to Market® - October 2022

Multiple Authors

Bylined Articles

October 20, 2022

Copyright Compliance Tips Ahead of Justices' Warhol Ruling

Law360 Ivy Clarice Estoesta, William H. Milliken

In the News

October 14, 2022

Skilled in the Art With Scott Graham

Law.com Ivy Clarice Estoesta, William H. Milliken

In the News

October 13, 2022

SCOTUS Flinches at ‘Extremes’ in Warhol ‘Prince’ Case

World Intellectual Property Review Ivy Clarice Estoesta, William H. Milliken

Client Alert

October 6, 2022

Justices to Hear Blockbuster Warhol Case Involving “Fair Use” Defense to Copyright Infringement

Ivy Clarice Estoesta, William H. Milliken

Press Release

September 9, 2022

Sterne Kessler Wins Hatch-Waxman Impact Case of the Year Award at 2022 LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox Ivy Clarice Estoesta, William H. Milliken

Firm Announcements

August 8, 2022

Sterne Kessler Raises Over $34,000 for the Legal Aid Society of the District of Columbia

Sterne, Kessler, Goldstein & Fox Multiple Authors

Client Alert

June 30, 2022

Supreme Court Denies Review in American Axle

William H. Milliken

In the News

June 30, 2022

Ignoring Solicitor General, Supreme Court Declines Patent Eligibility Case

National Law Journal William H. Milliken

Bylined Articles

June 1, 2022

5 Observations on Solicitor General's Patent Eligibility Brief

Law360 William H. Milliken

Bylined Articles

May 27, 2022

Patent Eligibility: What’s Going On With ‘American Axle’?

Westlaw Today Deirdre M. Wells, William H. Milliken

In the News

May 27, 2022

Hirshfeld's Arthrex Clearance Empowers Interim Leaders

Law360 Deirdre M. Wells, William H. Milliken

In the News

May 26, 2022

Cell Tech Co. Wants Patent Suits Grouped in Lone Star State

Law360 Deirdre M. Wells, William H. Milliken

In the News

May 10, 2022

SDNY Finds Patent for Processing Financial Transaction Data Invalid Under 101

IPWatchdog Deirdre M. Wells, William H. Milliken

In the News

May 6, 2022

Fed. Circ. Rejects Narcan Maker's Redo Bid In Patent Suit

Law360 Deirdre M. Wells, William H. Milliken

In the News

May 6, 2022

Skilled in the Art With Scott Graham

Law.com Deirdre M. Wells, William H. Milliken

In the News

May 4, 2022

Dorsey’s Block Slips Suit Saying It Copied Payments Software (2)

Bloomberg Law Deirdre M. Wells, William H. Milliken

Firm Announcements

May 3, 2022

District Court Patent Win for Client Block, Inc.

Sterne, Kessler, Goldstein & Fox Deirdre M. Wells, William H. Milliken

In the News

April 26, 2022

Pennsylvania Prison Beats Patent Suit Over Scanning Inmate Mail

Bloomberg Law Deirdre M. Wells, William H. Milliken

Firm Announcements

April 25, 2022

District Court Patent Victory in Infringement Suit

Sterne, Kessler, Goldstein & Fox Deirdre M. Wells, William H. Milliken

In the News

April 19, 2022

Fed. Circ. Revives Rovi Patent That Comcast Got PTAB To Ax

Law360 Deirdre M. Wells, William H. Milliken

In the News

March 21, 2022

High Court Turns Down Intel's Challenge to PTAB's Fintiv Rule

Law360 Deirdre M. Wells, William H. Milliken

In the News

March 8, 2022

Sens. Cruz, Lee Brief High Court in Vet's Disability Denial Row

Law360 Deirdre M. Wells, William H. Milliken

In the News

February 18, 2022

Litigator of the Week Runners-Up and Shout Outs

Law.com Deirdre M. Wells, William H. Milliken

Webinar Recordings & Materials

February 17, 2022

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Deirdre M. Wells, William H. Milliken

In the News

February 11, 2022

Federal Circuit Tosses Naloxone Patents

Law Street Media Deirdre M. Wells, William H. Milliken

In the News

February 10, 2022

Teva Win Invalidating Narcan Patents Upheld by Federal Circuit

Bloomberg Law Deirdre M. Wells, William H. Milliken

In the News

February 10, 2022

Court Affirms Teva Win in Fight Over Generic Narcan Anti-Overdose Drug

Reuters Deirdre M. Wells, William H. Milliken

In the News

February 10, 2022

Split Fed. Circ. Won't Restore 4 Narcan Patents

Law360 Deirdre M. Wells, William H. Milliken

Client Alert

February 7, 2022

IP Hot Topic: Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Deirdre M. Wells, William H. Milliken

Press Release

February 7, 2022

Sterne Kessler Releases Report Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Sterne, Kessler, Goldstein & Fox Deirdre M. Wells, William H. Milliken

Reports

February 3, 2022

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

February 3, 2022

United States v. Arthrex, 141 S. Ct. 1970 (2021)

Sterne, Kessler, Goldstein & Fox William H. Milliken

Bylined Articles

February 3, 2022

Kannuu Pty Ltd. v. Samsung Elecs. Co. Ltd., 15 F.4th 1101 (Fed. Cir. 2021)

Sterne, Kessler, Goldstein & Fox William H. Milliken

Bylined Articles

February 3, 2022

In re Vivint, Inc., 14 F.4th 1342 (Fed. Cir. 2021)

Sterne, Kessler, Goldstein & Fox William H. Milliken

Reports

January 14, 2022

PTAB Bar Association 2021 Appellate Year in Review

PTAB Bar Association Multiple Authors

Bylined Articles

January 4, 2022

Considering IP Venue Selection Through Eyes of Historical Assertion Data

Westlaw Today Deirdre M. Wells, William H. Milliken

In the News

December 23, 2021

The Most-Read IP Law360 Guest Articles of 2021

Law360 Deirdre M. Wells, William H. Milliken

Bylined Articles

December 1, 2021

In Review and Moving Forward

Intellectual Property Magazine William H. Milliken, Jamie Dohopolski

In the News

September 29, 2021

Fed. Circ. Rules 'Abusive' IPRs Can't Be Revived As Reexams

Law360 William H. Milliken, Jamie Dohopolski

In the News

September 29, 2021

Vivint Wins Reprieve From Fed Circ. on PTO Patent Reexamination

Reuters William H. Milliken, Jamie Dohopolski

In the News

September 29, 2021

Fed. Cir. Limits Review of Serial Patent Challenges (Correct)

Bloomberg Law William H. Milliken, Jamie Dohopolski

Bylined Articles

September 21, 2021

The Curious Case of Patent-Infringement Pleading Standards

Westlaw Today Multiple Authors

In the News

August 16, 2021

Fed. Circ. Axes Teva Antibody IP But Allows Treatment Patents

Law360 Multiple Authors

In the News

August 16, 2021

Teva Win on Three Migraine Drug Patents, Losses on Six Upheld

Bloomberg Law Multiple Authors

Bylined Articles

July 30, 2021

Arthrex: One Month Later

Sterne, Kessler, Goldstein & Fox William H. Milliken

Bylined Articles

July 8, 2021

Open Questions Following Minerva v. Hologic

Westlaw Today Jason D. Eisenberg, William H. Milliken

In the News

July 6, 2021

The Sharpest Dissents From The Supreme Court Term

Law360 Jason D. Eisenberg, William H. Milliken

PTAB Strategies and Insights

June 30, 2021

PTAB Strategies and Insights Newsletter - June 2021

Multiple Authors

In the News

June 30, 2021

Industry Commenters Say Minerva Ruling is a Win for Employee Mobility

IPWatchdog Multiple Authors

In the News

June 30, 2021

SCOTUS Upholds ‘Century-Old’ Assignor Estoppel Doctrine

Intellectual Property Magazine Multiple Authors

Client Alert

June 29, 2021

What You Should Know About the Supreme Court's Decision in Minerva

William H. Milliken

Bylined Articles

June 28, 2021

Evidentiary Obstacles for Third-Party Source Code in 'Wi-LAN v. Sharp Electronics'

Westlaw Today Multiple Authors

Bylined Articles

June 22, 2021

5 Practical Takeaways From High Court Arthrex Ruling

Law360 William H. Milliken

In the News

June 22, 2021

High Court Patent Review Ruling Helps Agency Head Shape Results

Bloomberg Law William H. Milliken

Client Alert

June 21, 2021

What You Should Know About the Supreme Court's Decision in Arthrex

William H. Milliken

In the News

June 21, 2021

SCOTUS Limits Patent Judges’ Power but Preserves PTAB Review

MedCity News William H. Milliken

In the News

June 21, 2021

US Supreme Court Gives PTO Director Chance To Impact Outcome Of Patent Disputes

Pink Sheet William H. Milliken

In the News

June 21, 2021

Industry Reacts to the Supreme Court’s Arthrex Ruling: Chaos Averted – or Just Delayed?

IPWatchdog William H. Milliken

In the News

June 7, 2021

Fed. Circ. Mulls Mixed PTAB Rulings In Teva Antibody IP Fight

Law360 William H. Milliken

Bylined Articles

April 28, 2021

Assignor Estoppel: Can’t We Just Leave It To Congress? (Answer: Not Really)

IPWatchdog William H. Milliken

In the News

April 23, 2021

Skilled in the Art

Law.com William H. Milliken

In the News

April 23, 2021

This Week in IP: Germany Wipes up Litigation, SCOTUS Hears Minerva, Chanel Loses Huawei TM Battle

Managing IP William H. Milliken

In the News

April 21, 2021

Justices Lean Toward Limiting, Not Eliminating, Assignor Estoppel Doctrine in Minerva v. Hologic

IPWatchdog William H. Milliken

In the News

April 21, 2021

Justices Eye Narrowing Bar On Patent Attacks, Not Ending It

Law360 William H. Milliken

Client Alert

April 16, 2021

Live Tweeting Minerva SCOTUS Oral Arguments on Wednesday, April 21, 2021

William H. Milliken

PTAB Strategies and Insights

March 29, 2021

PTAB Strategies and Insights - March 2021

Jason D. Eisenberg, William H. Milliken

Bylined Articles

March 23, 2021

3 Arthrex-Adjacent High Court Cases Could Affect PTAB's Fate

Law360 William H. Milliken

In the News

March 15, 2021

Federal Circuit Backs Caterpillar Rival's Patent Win

Law360 William H. Milliken

Bylined Articles

March 4, 2021

Patent Judge Appointments: Potential Outcomes From the Supreme Court

Bloomberg Law William H. Milliken

In the News

March 2, 2021

Amici and Practitioners Attempt to Read the Arthrex Tea Leaves

IPWatchdog William H. Milliken

In the News

March 2, 2021

Arthrex Hearing: Justices Wrangle with ‘Tough Questions’

Intellectual Property Magazine William H. Milliken

Client Alert

February 26, 2021

Arthrex SCOTUS Oral Arguments on Monday! We'll Be Live Tweeting Updates

William H. Milliken

In the News

February 25, 2021

The Supreme Court PTAB Cases That Came Before Arthrex

Law360 William H. Milliken

Press Release

January 27, 2021

Sterne Kessler Publishes New Report “Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2020 Decisions”

Sterne, Kessler, Goldstein & Fox William H. Milliken

Reports

January 26, 2021

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2020 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

January 26, 2021

United States v. Arthrex, Inc., No. 19-1434 (U.S.)

Sterne, Kessler, Goldstein & Fox William H. Milliken

Press Release

January 13, 2021

Sterne Kessler Elects Three New Directors and Promotes Four Attorneys to Counsel

Sterne, Kessler, Goldstein & Fox William H. Milliken

In the News

December 18, 2020

Fed. Circ. Agrees That Caterpillar ITC Patent Claim Is Invalid

Law360 William H. Milliken

In the News

November 3, 2020

Justices Skip Case Horizon Said Puts 32K Patents At Risk

Law360 William H. Milliken

PTAB Strategies and Insights

October 21, 2020

PTAB Strategies and Insights - October 2020

Jason D. Eisenberg, William H. Milliken

Client Alert

October 14, 2020

Five Things to Know About the Supreme Court’s Grant of Certiorari in Arthrex

William H. Milliken

In the News

October 14, 2020

Patent Reviews in ‘Limbo’ As Supreme Court Takes Case on Judges

Bloomberg Law William H. Milliken

Bylined Articles

October 13, 2020

Predictions For High Court Review Of Arthrex

Law360 William H. Milliken

In the News

October 13, 2020

Patent Stakeholders Weigh in on High Court Decision to Hear Arthrex

IPWatchdog William H. Milliken

In the News

October 13, 2020

Patent Law Is Just The Beginning For High Court In Arthrex

Law360 William H. Milliken

In the News

October 1, 2020

Teva Unit Tells High Court Not To Take Up Horizon's IP Loss

Law360 William H. Milliken

PTAB Strategies and Insights

April 23, 2020

PTAB Strategies and Insights - April 2020

Multiple Authors

Bylined Articles

April 23, 2020

The Federal Circuit Clarifies The Notice Requirements Of The Administrative Procedure Act for Motions To Amend

Sterne, Kessler, Goldstein & Fox William H. Milliken

Client Alert

April 21, 2020

Supreme Court Holds That PTAB Time-Bar Rulings Are Non-Appealable

William H. Milliken

In the News

April 20, 2020

PTAB Time-Bar Fights Will Ramp Up After High Court Ruling

Law360 William H. Milliken

Bylined Articles

March 23, 2020

Open Issues After Fed. Circ. PTAB Judge Appointments Ruling

Law360 Michael Joffre, Ph.D., William H. Milliken

In the News

March 23, 2020

Justices, Congress Might Tackle PTAB Constitutionality Next

Law360 Michael Joffre, Ph.D., William H. Milliken

Client Alert

March 4, 2020

IP Hot Topic: 2019 PTAB Year in Review: Analysis & Trends

Multiple Authors

Bylined Articles

February 28, 2020

Challenges to the Constitutionality of the Patent Trial and Appeal Board

Sterne, Kessler, Goldstein & Fox Lestin L. Kenton, Jr., William H. Milliken

Press Release

February 28, 2020

Sterne Kessler Publishes 2019 PTAB Year in Review Report

Sterne, Kessler, Goldstein & Fox P.L.L.C. Lestin L. Kenton, Jr., William H. Milliken

Reports

February 25, 2020

2019 PTAB Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Client Alert

February 3, 2020

IP Hot Topic: Federal Circuit Appeals from the PTAB: Summaries of Key 2019 Decisions

Michael Joffre, Ph.D.

Press Release

February 3, 2020

Sterne, Kessler, Goldstein & Fox Summarizes Key Decisions in 2019 Federal Circuit Appeals From The PTAB Report

Sterne, Kessler, Goldstein & Fox P.L.L.C. Michael Joffre, Ph.D.

Reports

January 24, 2020

Federal Circuit Appeals From The PTAB: Summaries of Key 2019 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

January 24, 2020

Arthrex v. Smith & Nephew, 941 F.3d 1320 (Fed. Cir. 2019)

Sterne, Kessler, Goldstein & Fox William H. Milliken

Bylined Articles

January 24, 2020

Regents of the Univ. of Minn. v. LSI Corp., 926 F.3d 1327 (Fed. Cir. 2019)

Sterne, Kessler, Goldstein & Fox William H. Milliken

In the News

November 21, 2019

Teva Gets PTAB To Review Cushing's Syndrome Drug Patent

Law360 William H. Milliken

Bylined Articles

November 14, 2019

Fed. Circ.’s Arthrex Ruling: Unforeseen Consequences For IPR

Law360 Multiple Authors

Firm Announcements

October 18, 2019

Firm Associate Secures Sua Sponte En Banc Ruling for Veterans Seeking VA Benefits

Multiple Authors

In the News

July 30, 2019

IBG, Broker Ask High Court To Clarify 'Confusing' CBM Rules

Law360 Multiple Authors

Firm Announcements

July 23, 2019

Firm Associate Secures Federal Circuit Precedent for Veterans Seeking VA Benefits

Multiple Authors

Firm Announcements

July 10, 2019

Sterne Kessler Succeeds in Receiving an En Banc Decision in United States of America v. Riley Briones, Jr., AKA Unknown Spitz

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

July 1, 2019

Fed. Circ. Lets Alice Invalidate Another Trading Tech Patent

Law360 Multiple Authors

In the News

June 13, 2019

Fed. Circ. Expanded Patent Law's Reach, Enplas Tells Justices

Law360 Multiple Authors

In the News

June 3, 2019

Supreme Court Refuses 'Blocking Patent' Rule Case

Law360 Multiple Authors

In the News

May 24, 2019

Fed. Circ. Backs Samsung, Apple In Interface Patent Fight

Law360 Multiple Authors

Press Release

April 8, 2019

Sterne Kessler Earns Recognition for “Impact” Litigation Case and Patent Prosecution at 2019 Managing Intellectual Property Awards

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

April 6, 2019

Fed. Circ. Won't Revisit Restasis Patent Ruling

Law360 Multiple Authors

In the News

March 7, 2019

Justices Urged To Turn Down PTAB Tribal Immunity Case

Law360 Multiple Authors

In the News

March 6, 2019

Fed. Circ. Won't Revisit Restasis Patent Ruling

Law360 Multiple Authors

Reports

February 19, 2019

2019 Report: Federal Circuit Appeals from the PTAB - Summaries of Key 2018 Decisions

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

February 15, 2019

Restasis Patent Redo Bid 'Inappropriate,' Fed. Circ. Told

Law360 Multiple Authors

In the News

January 22, 2019

Fed. Circ. Affirms Toshiba Win Over LCD Screen IP Suit

Law360 Multiple Authors

In the News

December 12, 2018

Fed. Circ. OKs Teva's Patent Win Over Allergan Colitis Drug

Law360 Multiple Authors

In the News

December 6, 2018

Fed. Circ. Questions Allergan On Water's Role In Colitis Patent

Law360 Multiple Authors

In the News

November 13, 2018

Fed. Circ. Won't Restore Allergan's Restasis Patent Claims

Law360 Multiple Authors

In the News

November 6, 2018

Fed. Circ. Urged Not to Stay Immunity Ruling for Appeal

Law360 Multiple Authors

In the News

October 31, 2018

Allergan, Generic Cos. Battle Over Restasis Launch Plans

Law360 Multiple Authors

In the News

October 26, 2018

Allergan, Tribe Want IPRs Blocked As They Turn To High Court

Law360 Multiple Authors

In the News

October 22, 2018

Fed. Circ. Rejects Bid For PTAB Tribal Immunity Rehearing

Law360 Multiple Authors

In the News

September 19, 2018

No Need To Reconsider Immunity At PTAB, Fed. Circ. Hears

Law360 Multiple Authors

In the News

September 7, 2018

States Back Tribe, Allergan Fed. Circ. Bid For PTAB Immunity

Law360 Multiple Authors

In the News

September 4, 2018

Generics Cos. Urge Fed. Circ. To Upend Depomed Patent Win

Law360 Multiple Authors

In the News

August 29, 2018

Fed. Circ. Impeding Biopharma Innovation, Justices Told

Law360 Multiple Authors

In the News

August 20, 2018

Allergan, Tribe Want PTAB Immunity Denial Reheard En Banc

Law360 Multiple Authors

In the News

July 20, 2018

Fed. Circ. Says Tribal Immunity Doesn't Apply In IPR

Law360 Multiple Authors

In the News

March 26, 2018

Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRs

Law360 Multiple Authors

In the News

March 8, 2018

Don't Revive Restasis Patents, Generic Cos. Urge Fed. Circ.

Law360 Multiple Authors

Reports

March 1, 2018

2018 Report: Federal Circuit Appeals from the PTAB - Summaries of Key 2017 Decisions

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

November 30, 2017

High Court Split on Forcing Patent Office to Cover All Arguments

Blomberg BNA Multiple Authors

Bylined Articles

June 29, 2017

PTAB Decisions May Face Chenery Attacks at Fed. Circ.

Law360 William H. Milliken

Bylined Articles

June 16, 2017

Supreme Court to Review Constitutionality of Inter Partes Review Process

Bloomberg BNA John Christopher “J.C.” Rozendaal, William H. Milliken